Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lingen

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Journal of the American Dental Association (1939)|May 4, 2010
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomasMichael P Rethman, William Carpenter, Ezra E W Cohen, et al.
JAMA Oncology|November 6, 2015
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical TrialWilliam N William, Vassiliki Papadimitrakopoulou, J Jack Lee, et al.
Cancer Research|October 27, 2012
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancersRifat Hasina, Nathan Mollberg, Ichiro Kawada, et al.
Nature Communications|August 17, 2022
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancerManijeh Goldberg, Aaron Manzi, Amritpreet Birdi, et al.
Lancet Regional Health. Americas|June 16, 2025
Automated classification of oral potentially malignant disorders and oral squamous cell carcinoma using a convolutional neural network framework: a cross-sectional studyCristina Saldivia-Siracusa, Eduardo Santos Carlos de Souza, Arnaldo Vitor Barros da Silva, et al.
Oral Oncology|February 13, 2025
Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in TaiwanCheng-Ping Wang, Kelly J Yu, Tseng-Cheng Chen, et al.
Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.
Cell Reports|July 18, 2023
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neckNupur Nigam, Benjamin Bernard, Samantha Sevilla, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Journal of the American Dental Association (1939)|May 4, 2010
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomasMichael P Rethman, William Carpenter, Ezra E W Cohen, et al.
JAMA Oncology|November 6, 2015
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical TrialWilliam N William, Vassiliki Papadimitrakopoulou, J Jack Lee, et al.
Cancer Research|October 27, 2012
Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancersRifat Hasina, Nathan Mollberg, Ichiro Kawada, et al.
Nature Communications|August 17, 2022
A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancerManijeh Goldberg, Aaron Manzi, Amritpreet Birdi, et al.
Lancet Regional Health. Americas|June 16, 2025
Automated classification of oral potentially malignant disorders and oral squamous cell carcinoma using a convolutional neural network framework: a cross-sectional studyCristina Saldivia-Siracusa, Eduardo Santos Carlos de Souza, Arnaldo Vitor Barros da Silva, et al.
Oral Oncology|February 13, 2025
Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in TaiwanCheng-Ping Wang, Kelly J Yu, Tseng-Cheng Chen, et al.
Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.
Cell Reports|July 18, 2023
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neckNupur Nigam, Benjamin Bernard, Samantha Sevilla, et al.
Pageof 12